Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System
(JJ-TRAILS)
8 other identifiers
interventional
839
1 country
8
Brief Summary
This is a multi site experiment to evaluate the impact of various strategies for increasing the use of evidence based screening, assessment and linkage to substance use treatment. All sites collect baseline data and receive a core intervention. Half are then randomly assigned to get an additional year of coaching to facilitate implementation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2013
Longer than P75 for not_applicable
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 22, 2016
CompletedFirst Posted
Study publicly available on registry
February 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedJuly 23, 2019
July 1, 2019
5.6 years
January 22, 2016
July 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Service Cascade: % Referred to Substance Use Treatment
Calculated from juvenile justice and substance use treatment agency records as the number of youth referred to substance use treatment divided by the number of youth identified as need of substance use treatment.
120 weeks
Staff Perception: Value of Evidenced Based Substance Use Treatment
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based substance use treatment services.
120 weeks
Secondary Outcomes (13)
Service Cascade: % Screened for Substance Use Problems
120 weeks
Service Cascade: % Clinically Assessed for Substance Use Problems
120 weeks
Service Cascade: % In Need of Substance Use Treatment
120 weeks
Service Cascade: % Initiating Substance Use Treatment
120 weeks
Service Cascade: % Engaged in Substance Use Treatment
120 weeks
- +8 more secondary outcomes
Study Arms (3)
Control
NO INTERVENTIONDuring the Baseline Control data is collected in all 36 sites at the agency, staff, and youth level on the 6 months prior to the interventions in Arms 2 \& 3 to document what practice was before the study.
Core
ACTIVE COMPARATORIn the second phase (after baseline) all 36 sites receive a Core condition that includes five interventions: (1) JJ-TRIALS Orientation Meetings, (2) Needs Assessment, (3) Behavioral Health Training, (4) Site Feedback Report, (5) Goal Achievement Training, (6) Monthly Site Check-ins, and (7) Quarterly Reports. As part of Goal Achievement Training, sites receive assistance in using their Site Feedback Reports to select goals to meet their local needs. Sites are trained on using Data-Driven Decision Making (DDDM) to inform decisions (e.g., selecting a goal, monitoring progress) and enlisting DDDM templates and tools (developed as part of the project) to plan and implement proposed changes. these principles to their improvement efforts during the implementation phase.
Enhanced
EXPERIMENTALWhile the core intervention and DDDM are expected to facilitate change, organizations may need additional support to apply these principles to their improvement efforts during the implementation phase. In the third phase (after Core), 1/2 of the sites are randomly assigned to an Enhanced condition that provides continuing support for the use of DDDM tools by adding research staff facilitation of DDDM over a 12-month period and formalized Local Change Teams (LCTs) featuring representation from the JJ agency and a local BH provider, with meetings facilitated by research staff).
Interventions
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chestnut Health Systemslead
- National Institute on Drug Abuse (NIDA)collaborator
- Columbia Universitycollaborator
- Emory Universitycollaborator
- Mississippi State Universitycollaborator
- Temple Universitycollaborator
- Texas Christian Universitycollaborator
- University of Kentuckycollaborator
Study Sites (8)
Emory University
Atlanta, Georgia, 30322, United States
Chestnut Health Systems
Bloomington, Illinois, 61701, United States
University of Kentucky
Lexington, Kentucky, 40508, United States
National Institute on Drug Abuse
Rockville, Maryland, 20892, United States
Mississippi State University
Starkville, Mississippi, 39759, United States
Columbia University
New York, New York, 10032, United States
Temple University
Philadelphia, Pennsylvania, 19122, United States
Texas Christian University
Fort Worth, Texas, 76129, United States
Related Publications (8)
Jones SD, Bartkowski JP, Belenko S, Becan JE, Taxman FS, Wasserman GA, Aarons GA, McReynolds LS, Dolbear C, Xu X. Site engagement in implementation research: Introducing SEAMLIS as a conceptual and measurement framework. Health Justice. 2025 Jul 5;13(1):44. doi: 10.1186/s40352-025-00349-1.
PMID: 40616691DERIVEDNelson V, Wood J, Belenko S, Pankow J, Piper K. Conditions of successful treatment referral practices with justice-involved youth: Qualitative insights from probation and service provider staff involved in JJ-TRIALS. J Subst Use Addict Treat. 2024 Jul;162:209358. doi: 10.1016/j.josat.2024.209358. Epub 2024 Mar 27.
PMID: 38548060DERIVEDBelenko S, Dembo R, Knight DK, Elkington KS, Wasserman GA, Robertson AA, Welsh WN, Schmeidler J, Joe GW, Wiley T. Using structured implementation interventions to improve referral to substance use treatment among justice-involved youth: Findings from a multisite cluster randomized trial. J Subst Abuse Treat. 2022 Sep;140:108829. doi: 10.1016/j.jsat.2022.108829. Epub 2022 Jun 19.
PMID: 35751945DERIVEDMarks KR, Leukefeld CG, Dennis ML, Scott CK, Funk R; JJ-TRIALS Cooperative. Geographic differences in substance use screening for justice-involved youth. J Subst Abuse Treat. 2019 Jul;102:40-46. doi: 10.1016/j.jsat.2019.04.005. Epub 2019 Apr 13.
PMID: 31202287DERIVEDFisher JH, Becan JE, Harris PW, Nager A, Baird-Thomas C, Hogue A, Bartkowski JP, Wiley T; JJ-TRIALS Cooperative. Using Goal Achievement Training in juvenile justice settings to improve substance use services for youth on community supervision. Health Justice. 2018 Apr 30;6(1):10. doi: 10.1186/s40352-018-0067-4.
PMID: 29713840DERIVEDBecan JE, Bartkowski JP, Knight DK, Wiley TRA, DiClemente R, Ducharme L, Welsh WN, Bowser D, McCollister K, Hiller M, Spaulding AC, Flynn PM, Swartzendruber A, Dickson MF, Fisher JH, Aarons GA. A model for rigorously applying the Exploration, Preparation, Implementation, Sustainment (EPIS) framework in the design and measurement of a large scale collaborative multi-site study. Health Justice. 2018 Apr 13;6(1):9. doi: 10.1186/s40352-018-0068-3.
PMID: 29654518DERIVEDBelenko S, Knight D, Wasserman GA, Dennis ML, Wiley T, Taxman FS, Oser C, Dembo R, Robertson AA, Sales J. The Juvenile Justice Behavioral Health Services Cascade: A new framework for measuring unmet substance use treatment services needs among adolescent offenders. J Subst Abuse Treat. 2017 Mar;74:80-91. doi: 10.1016/j.jsat.2016.12.012. Epub 2016 Dec 31.
PMID: 28132705DERIVEDKnight DK, Belenko S, Wiley T, Robertson AA, Arrigona N, Dennis M, Bartkowski JP, McReynolds LS, Becan JE, Knudsen HK, Wasserman GA, Rose E, DiClemente R, Leukefeld C; JJ-TRIALS Cooperative. Juvenile Justice-Translational Research on Interventions for Adolescents in the Legal System (JJ-TRIALS): a cluster randomized trial targeting system-wide improvement in substance use services. Implement Sci. 2016 Apr 29;11:57. doi: 10.1186/s13012-016-0423-5.
PMID: 27130175DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tisha R Wiley, Ph.D.
National Institute on Drug Abuse (NIDA)
- PRINCIPAL INVESTIGATOR
Gail A Wasserman, Ph.D.
Columbia University
- PRINCIPAL INVESTIGATOR
Ralph DiClemente, Ph.D.
Emory University
- PRINCIPAL INVESTIGATOR
Gene H Brody, Ph.D.
Emory University
- PRINCIPAL INVESTIGATOR
Angela A Robertson, Ph.D.
Mississippi State University
- PRINCIPAL INVESTIGATOR
Steven R Belenko, Ph.D.
Temple University
- PRINCIPAL INVESTIGATOR
Danica K Knight, Ph.D.
Texas Christian University
- PRINCIPAL INVESTIGATOR
Carl G Leukefeld, Ph.D.
University of Kentucky
- PRINCIPAL INVESTIGATOR
Michael L Dennis, Ph.D.
Chestnut Health Systems
- PRINCIPAL INVESTIGATOR
Christy K Scott, Ph.D.
Chestnut Health Systems
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Pairs of sites were optimally randomize based on 10,000 trials to the two conditions by the coordinating center. The assignment (to core or core+enhanced) was not revealed to the local research center or site until after completion of the core. Thus it is double blind.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Coordinating Center Multi-PI
Study Record Dates
First Submitted
January 22, 2016
First Posted
February 3, 2016
Study Start
July 1, 2013
Primary Completion
January 31, 2019
Study Completion
June 30, 2019
Last Updated
July 23, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will share
The coordinating center is charged with creating de-identified versions of agency, staff and client level service data available at the end of the study.